Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6414381

CC(=O)Nc1ccc(OCCC[N+]2(C)CCC(OC(=O)C3c4ccccc4Oc4ccccc43)C2)cc1.COC(=O)c1ccc(OCCC[N+]2(C)CCC(OC(=O)C3c4ccccc4Oc4ccccc43)C2)cc1.O=C([O-])C(F)(F)F.O=C([O-])C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 9/20 0.44
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 2/20 0.40
CHRM2 P08172 6/20 0.40
CHRM1 P11229 6/20 0.40
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 1/20 0.34
HTR2A P28223 2/20 0.34
CCR1 P32246 2/20 0.33
HTR1A P08908 1/20 0.33
DRD2 P14416 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5534438 0.95 CHRM3 (0.48) CHRM3MEN1KMT2AMAPTCHRM2
Trifluoroacetic Acid SCHEMBL5546014 0.94 CHRM3 (0.49) CHRM3MEN1KMT2AMAPTCHRM2
SCHEMBL6423109 0.89 CHRM3 (0.54) CHRM3MEN1KMT2AMAPTCHRM2
Trifluoroacetic Acid SCHEMBL6420994 0.88 CHRM3 (0.45) CHRM3MEN1KMT2AMAPTCHRM2
Trifluoroacetic Acid SCHEMBL5538285 0.84 CHRM3 (0.50) CHRM3CHRM2CHRM1CCR1
Trifluoroacetic Acid SCHEMBL5533187 0.83 CHRM3 (0.49) CHRM3CHRM2CHRM1KDM4ECCR1
Trifluoroacetic Acid SCHEMBL5535488 0.81 CHRM3 (0.46) CHRM3MEN1KMT2AMAPTCHRM2
Trifluoroacetic Acid SCHEMBL5544783 0.79 CHRM3 (0.49) CHRM3CHRM2CHRM1CCR1
Trifluoroacetic Acid SCHEMBL5538291 0.78 CHRM3 (0.44) CHRM3MEN1KMT2AMAPTCHRM2
SCHEMBL6417797 0.77 CHRM3 (0.54) CHRM3CHRM2CHRM1KDM4ECCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497284-A2 PYRROLIDINIUM DERIVATIVES AS ANTAGONISTS OF M3 MUSCARINIC RECEPTORS Almirall Prodesfarma AG (CH) 2005-01-19 EP disclosed
WO-2003087094-A2 PYRROLIDINIUM DERIVATIVES AS ANTAGONISTS OF M3 MUSCARINIC RECEPTORS ALMIRALL PRODESFARMA AG (CH) 2003-10-23 WO disclosed